Methotrexat Accord

Methotrexate, the active ingredient in Methotrexat Accord, is an antimetabolite presented as a sterile injectable for intraarterial, intramuscular, and intrathecal use. It is employed in the management of rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia and osteosarcoma in adult and pediatric patients.

GNH USA supplies Methotrexat Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexat Accord is an antimetabolite used across several disease families, primarily inflammatory and malignant conditions. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: limits skin cell proliferation, improving plaque severity. - Acute lymphoblastic leukemia: interferes with malignant cell DNA synthesis, aiding remission. - Osteosarcoma: contributes to tumor growth inhibition as part of combination chemotherapy.

Methotrexat Accord may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset common during therapy. - Fatigue: persistent tiredness reported by many patients. - Mucositis: inflammation of the mouth lining. - Elevated liver enzymes: mild hepatic enzyme rise.

Serious or Rare Side Effects: - Bone marrow suppression: leading to anemia, leukopenia or thrombocytopenia. - Severe liver toxicity: potential for hepatitis or fibrosis. - Pulmonary fibrosis: interstitial lung disease with dyspnea. - Renal failure: impaired kidney function requiring monitoring. - Anaphylactic reaction: rare hypersensitivity requiring immediate care.

Before initiating therapy, clinicians should assess baseline health status and monitor for toxicity. - Blood count monitoring: perform regular CBC to detect marrow suppression. - Liver function assessment: check transaminases before and during treatment. - Renal function evaluation: adjust dosing if creatinine clearance is reduced. - Pregnancy avoidance: contraindicated in pregnancy; ensure effective contraception. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Methotrexat Accord interacts with several medicines that can alter its efficacy or safety.

Major Interactions (Avoid): - NSAIDs: increase risk of renal toxicity and gastrointestinal ulceration. - Trimethoprim‑sulfamethoxazole: potentiates bone marrow suppression. - Pemetrexed: additive antifolate toxicity.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may reduce renal clearance of methotrexate. - Live vaccines: risk of severe infection due to immunosuppression.